UBS Group »

Aeon Biopharma shares owned by UBS Group

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aeon Biopharma

Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 202520k40k60k020k40k60k
Value ($)Share countHistorical AEON position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $26k 49k 0.54
2024-09-30 $61k 58k 1.05
2023-12-31 $4.7k 649 7.20

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Aeon Biopharma

Blue Owl Capital Holdings
Polar Securities
Vanguard Group
BBK Capital Partners
BlackRock
Ikarian Capital
Geode Capital Management
Bank of America Corporation
Caprock
State Street Corporation
Boothbay Fund Management
Two Sigma Investments
Bridgeway Capital Management
LMR Partners
UBS Group

View all funds holding Aeon Biopharma